NAYA Valuation
NAYA Biosciences Inc
$
0.000
- Overview
- Forecast
- Valuation
- Earnings
NAYA Relative Valuation
NAYA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NAYA is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-0.05
P/B
Median3y
-0.09
Median5y
-0.09
0.00
FCF Yield
Median3y
0.00
Median5y
0.00
Competitors Valuation Multiple
The average P/S ratio for NAYA's competitors is 0.80, providing a benchmark for relative valuation. NAYA Biosciences Inc Corp (NAYA) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of 47.01%, this premium appears sustainable.
People Also Watch
ATXI
Avenue Therapeutics Inc
0
USD
-102.86%
SNOA
Sonoma Pharmaceuticals Inc
3.420
USD
-4.89%
NIVF
NewGenIvf Group Ltd
0.520
USD
-5.11%
EVAX
Evaxion A/S
2.720
USD
+0.37%
ENVB
Enveric Biosciences Inc
1.310
USD
-0.76%
MYSZ
My Size Inc
1.370
USD
-0.72%
INM
InMed Pharmaceuticals Inc
2.640
USD
-1.49%
UPXI
Upexi Inc
6.110
USD
-4.68%
ZVSA
Zyversa Therapeutics Inc
0
USD
-76.45%
NBY
NovaBay Pharmaceuticals Inc
0.672
USD
+3.22%
FAQ
Is NAYA Biosciences Inc (NAYA) currently overvalued or undervalued?
NAYA Biosciences Inc (NAYA) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of -1.60. The fair price of NAYA Biosciences Inc (NAYA) is between to according to relative valuation methord.
What is NAYA Biosciences Inc (NAYA) fair value?
How does NAYA's valuation metrics compare to the industry average?
What is the current P/B ratio for NAYA Biosciences Inc (NAYA) as of Jul 28 2025?
What is the current FCF Yield for NAYA Biosciences Inc (NAYA) as of Jul 28 2025?
What is the current Forward P/E ratio for NAYA Biosciences Inc (NAYA) as of Jul 28 2025?